EV Biologics

EV Biologics, Inc. is a biotechnology company focused on innovation in the development of engineered exosome-based therapeutics to create next-generation biopharmaceuticals that target specific cells and tissues involved in diseases and injuries with bioactive molecules. Our exosome design, engineering, and research systems are aimed at leveraging technology to optimize biopharmaceutical discovery, scalable GMP biomanufacturing, preclinical development, and clinical trials to quickly bring safe, effective, FDA-approved biopharmaceuticals into practice.